Jazz Pharmaceuticals (Germany) Today
| J7Z Stock | EUR 116.85 1.15 0.97% |
Performance11 of 100
| Odds Of DistressLess than 30
|
Jazz Pharmaceuticals is trading at 116.85 as of the 22nd of December 2024. This is a 0.97 percent decrease since the beginning of the trading day. The stock's lowest day price was 116.35. Jazz Pharmaceuticals has about a 30 percent probability of financial distress in the next few years of operation but had a somewhat good performance during the last 90 days. The performance scores are derived for the period starting the 23rd of September 2024 and ending today, the 22nd of December 2024. Click here to learn more.
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. Jazz Pharmaceuticals plc has licensing and collaboration agreements with ImmunoGen, Inc. The company has 62.97 M outstanding shares. More on Jazz Pharmaceuticals plc
Moving against Jazz Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Jazz Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Jazz Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Jazz Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman of the Board, CEO | Bruce Cozadd |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Jazz Pharmaceuticals plc (J7Z) is traded on Frankfurt Exchange in Germany and employs 3,200 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 8.38 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Jazz Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Jazz Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Jazz Pharmaceuticals plc classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 62.97 M outstanding shares.
Jazz Pharmaceuticals plc has accumulated about 833.95 M in cash with 778.51 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 14.72.
Check Jazz Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationJazz Pharmaceuticals plc has a total of 62.97 Million outstanding shares. The majority of Jazz Pharmaceuticals plc outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Jazz Pharmaceuticals to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Jazz Pharmaceuticals plc. Please pay attention to any change in the institutional holdings of Jazz Pharmaceuticals plc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Jazz Ownership Details
Jazz Pharmaceuticals plc Risk Profiles
Although Jazz Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Jazz Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.5 | |||
| Semi Deviation | 1.51 | |||
| Standard Deviation | 2.01 | |||
| Variance | 4.03 |
Jazz Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Jazz Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
Jazz Pharmaceuticals Corporate Management
Elected by the shareholders, the Jazz Pharmaceuticals' board of directors comprises two types of representatives: Jazz Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Jazz. The board's role is to monitor Jazz Pharmaceuticals' management team and ensure that shareholders' interests are well served. Jazz Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Jazz Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert MD | Ex RD | Profile | |
| Finbar Larkin | VP Operations | Profile | |
| George Eliades | Sr Officer | Profile | |
| Patricia Carr | VP Officer | Profile | |
| Heidi Manna | VP Officer | Profile | |
| Neena JD | Ex Officer | Profile |
Additional Information and Resources on Investing in Jazz Stock
When determining whether Jazz Pharmaceuticals plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Jazz Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Jazz Pharmaceuticals Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Jazz Pharmaceuticals Plc Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jazz Pharmaceuticals plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.